We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOC icon
301
Northrop Grumman
NOC
$73.2B
$202K ﹤0.01%
+397
New +$229K
NOVT icon
302
Novanta
NOVT
$5.61B
$201K ﹤0.01%
+1,239
New +$179K
VMI icon
303
Valmont Industries
VMI
$9.29B
$201K ﹤0.01%
+348
New +$175K
CVBF icon
304
CVB Financial
CVBF
$3.98B
$201K ﹤0.01%
+8,899
New +$183K
RPM icon
305
RPM International
RPM
$13.5B
$201K ﹤0.01%
+1,805
New +$188K
SXT icon
306
Sensient Technologies
SXT
$5.74B
$201K ﹤0.01%
+1,627
New +$181K
PSKY
307
Paramount Skydance Corp
PSKY
$12.2B
$200K ﹤0.01%
+20,254
New +$213K
BB icon
308
BlackBerry
BB
$4.51B
$199K ﹤0.01%
+15,712
New +$110K
FLO icon
309
Flowers Foods
FLO
$1.33B
$196K ﹤0.01%
+24,844
New +$199K
EXYNW
310
Exyn Technologies Warrant
EXYNW
$1.2M
$172K ﹤0.01%
+129,000
New +$115K
BGC icon
311
BGC Group
BGC
$5.79B
$168K ﹤0.01%
15,687
+155
+1% +$1.73K
BJDX icon
312
Bluejay Diagnostics
BJDX
$861K
$157K ﹤0.01%
+131,000
New +$339K
UUUU icon
313
Energy Fuels
UUUU
$3.83B
$146K ﹤0.01%
+10,081
New +$185K
TU icon
314
Telus
TU
$15.2B
$124K ﹤0.01%
11,737
+91
+0.8% +$1.11K
LCFYW icon
315
Locafy Ltd Warrant
LCFYW
$450K
$121K ﹤0.01%
12,121
– –
GIPR icon
316
Generation Income Properties
GIPR
$1.64M
$67K ﹤0.01%
+40,100
New +$103K
CELZ icon
317
Creative Medical Technology
CELZ
$7.32M
$60.9K ﹤0.01%
+42,000
New +$90.7K
TNON icon
318
Tenon Medical
TNON
$2.48M
$56.2K ﹤0.01%
+4,917
New +$118K
ENVB icon
319
Enveric Biosciences
ENVB
$6.22M
$44.2K ﹤0.01%
+32,000
New +$76.9K
BDRX
320
Biodexa Pharmaceuticals
BDRX
$873K
$43.1K ﹤0.01%
14,809
-4,695
-24% -$15.8K
MDCXW
321
Medicus Pharma Warrant
MDCXW
$306K
$39.4K ﹤0.01%
60,600
– –
CHGA
322
Change Agents Corp
CHGA
$2.55M
$35.7K ﹤0.01%
+6,129
New +$47.4K
NXGLW icon
323
NexGel Inc Warrant
NXGLW
$25.8K
$21.2K ﹤0.01%
550,000
– –
FGIWW
324
FGI Industries Warrant
FGIWW
$17.7K ﹤0.01%
186,666
– –
SWAGW icon
325
Stran & Company Warrant
SWAGW
$24.7K
$14.2K ﹤0.01%
545,000
– –
11 12
13
14 15

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.